Drug Trial Radar · NCT06656390
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
202
Planned (sponsor's estimate)
Start
Oct 24, 2024
Primary completion
Oct 22, 2027
Study completion Apr 22, 2028
Sponsor
- Lead sponsor
- Shanghai Allink Biotherapeutics Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a first-in-human (FIH), open-label, multicenter dose escalation and expansion study of ALK201. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and antitumor activity of ALK201 as a monotherapy in adult participants with Advanced Solid Tumors. The study will also identify recommended dose(s) for subsequent clinical studies of ALK201.
Conditions
- Advanced Cancer
- Advanced Solid Tumors
Interventions
ALK201Drug
Administered intravenously, once every 3 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the safety and tolerability of ALK201 in adult participants with advanced solid tumors; To determine the maximum tolerated dose (MTD); To determine the recommended dose(s) of ALK201 for subsequent clinical studies.Time frame: Approximately 36 months
Locations
38 sites in 3 countries. Site status is shown where the registry gives one.
Denver Drug Development Unit
Denver, Colorado · Recruiting
UCF Lake Nona Cancer Center
Orlando, Florida · Recruiting
University Medical Center New Orleans
New Orleans, Louisiana · Recruiting
Sarah Cannon Research Institute Oncology Partners
Nashville, Tennessee · Recruiting
Macquarie University Hospital
Macquarie, Australia · Recruiting
Cancer Care Wollongong
Wollongong, New South Wales, Australia · Recruiting
Sunshine Coast University Private Hospital
Birtinya, Queensland, Australia · Recruiting
Mater Cancer Care Center
South Brisbane, Queensland, Australia · Recruiting
ChongQing University Cancer Hospital
Chongqing, China · Recruiting
Anhui Provincial Cancer Hospital
Hefei, Anhui, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Fujian Medical University Union Hospital
Fuzhou, Fujian, China · Recruiting
The First Affiliated Hospital Of Xiamen University
Xiamen, Fujian, China · Recruiting
Guangdong Province People's Hospital
Guangzhou, Guangdong, China · Recruiting
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China · Recruiting
Cancer Hospital Of Shantou University Medical College
Shantou, Guangdong, China · Recruiting
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China · Recruiting
Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China · Recruiting
Harbin Medical University Canser Hospital
Harbin, Heilongjiang, China · Recruiting
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Hubei Cancer Hospital
Wuhan, Hubei, China · Recruiting
Tongji Hospital, Tongji Medical College of Hust
Wuhan, Hubei, China · Recruiting
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
The Central Hospital of Yongzhou
Yongzhou, Hunan, China · Recruiting
The First People's Hospital of Changzhou
Changzhou, Jiangsu, China · Recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China · Recruiting
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China · Recruiting
Xuzhou Central Hospital ( Southeast University Affiliated Hopstal )
Xuzhou, Jiangsu, China · Recruiting
First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangxi, China · Recruiting
Liaoning Cancer Hospital
Shenyang, Liaoning, China · Recruiting
Shandong Cancer Hospital
Jinan, Shandong, China · Recruiting
Shanghai East Hospital
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Yunnan Cancer Hospital
Kunming, Yunnan, China · Recruiting
Sir Run Run Shaw Hospital Zhejiang University School of Medical
Hangzhou, Zhejiang, China · Recruiting
The First Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.